MEI Pharma, Inc.

Q2 2023 13F Holders

Symbol
LITS
CUSIP
55279B301
Type
Equity
Class
COM
Num filings
30
Total reported value, excl. options
$15.0 M
Manager Report Date Value ($000) Shares Option Type